Diabete Type 2
124
25
30
41
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.4%
3 terminated out of 124 trials
93.2%
+6.6% vs benchmark
8%
10 trials in Phase 3/4
2%
1 of 41 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 41 completed trials
Clinical Trials (124)
PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses
Inflammation and Diabetes: Evaluating Antioxidant Levels
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B
Nutrition Intervention Optimization to Better Utilize Resources and Support Health
Type 2 Diabetes Mellitus and Downhill Aerobic Exercise Training
Normast3 for Adults With Diabetic Polyneuropathy
Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus
Peel Family Diabetes Prevention Program
Evaluate the Effect of Remote Exercise Intervention on Blood Glucose Control and Physical Fitness in T2DM Patients
Feasibility of a Person-centered Nursing Intervention on Adherence and Control in Patients With Arterial Hypertension and Diabetes Mellitus.
To Assess the Prevalence, Management Practices, and Clinical Outcomes Associated With Hyperglycemia Among Hospitalized Patients, With a Particular Focus on the Interplay Between Metabolic Biomarkers, Nutritional Status, and Body Composition
Pocket-X Gel Non-surgical Periodontal Therapy
Effect of Diode Laser, Gudmar and Vinegar in Diabetic Patients During Root Canal Treatment
Culturally Tailored Diabetes Education on Self-Management of Adult Hispanic Males With Type 2 Diabetes Mellitus
Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult Volunteers
Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting State
A Study to Compare the Pharmacokinetics and Safety of the ATB-U101 and ATB-U1011+ATB-U1012 and ATB-1011+ATB-1012 in Healthy Caucasian Participants
SGLT-2 Inhibitors in the Treatment of Ascites
Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.
Role of Endothelial Progenitor Cells Dysregulation and Inflammation in the Pathophysiology of Cardiovascular Complications of Type 2 Diabetes